Search
for
Sort by
Research 151–180 of 1000+
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- A review of Janus kinase inhibitor use in scarring alopecia
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Abstracts from the 2024 WDS Forum - virtual option
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Ritlecitinib (Litfulo)
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Under Development JAK Inhibitors for Dermatologic Diseases
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Application of Baricitinib in Dermatology
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Successful treatment of severe diffuse alopecia areata with abrocitinib